7-Hydroxy risperidone
CAS: 147663-04-5
Ref. 3D-FH24119
1mg | Discontinued | ||
2mg | Discontinued | ||
5mg | Discontinued | ||
10mg | Discontinued | ||
25mg | Discontinued |
Product Information
- 3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-7-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one
- 1,2-Benzisoxazole, 4H-pyrido[1,2-a]pyrimidin-4-one deriv.
- 3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-7-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
- 4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-7-hydroxy-2-methyl-
- 7-Hydroxy risperidone-d4
- 7-Hydroxyrisperidone
- R 79242
Paliperidone palmitate is a prodrug of risperidone and paliperidone. It is a biocompatible polymer that has been shown to be effective in the pharmacological treatment of schizophrenia. Paliperidone palmitate has been shown to have long-term efficacy, median plasma levels, and low drug interactions with other medications. This drug also has an effect on energy metabolism and plasma prolactin levels. Paliperidone palmitate may be used as an alternative treatment for hepatic impairment due to its low toxicity.